£495.00

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

Aneurysmal Subarachnoid Hemorrhage Drugs Outlook China 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 22 August 2026 31 August 2026 09 September 2026 18 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 38 days • 1 price levels

Days at Price
38 days 0 10 19 29 38 £495 Days at Price

Price Analysis

Most common price: £495 (38 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 38 days

Description

This comprehensive market research study examines the latent demand outlook for aneurysmal subarachnoid hemorrhage drugs across all regions of China, encompassing provinces, autonomous regions including Guangxi, Nei Mongol, Ningxia, Xinjiang and Xizang, major municipalities such as Beijing, Chongqing, Shanghai and Tianjin, and special administrative regions including Hong Kong and Macau plus Taiwan. The analysis provides detailed potential industry earnings estimates across approximately 1,100 cities in China, with each major city's market share calculated as a percentage of its corresponding region to enable precise demand forecasting and market opportunity identification for pharmaceutical stakeholders.

Key Features

Covers latent demand outlook for aneurysmal subarachnoid hemorrhage drugs across all Chinese regions and provinces.

Provides potential industry earnings estimates in millions of U.S. dollars for approximately 1,100 cities throughout China.

Includes market analysis for major municipalities such as Beijing, Chongqing, Shanghai and Tianjin.

Analyzes special administrative regions including Hong Kong, Macau and Taiwan within the broader China market framework.

Published by ICON Group International, Inc. with 2023-2028 forecast period for strategic planning purposes.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
24 August 2022

Similar Products You Might Like

2023-2028 Uterine Sarcoma Therapeutics & Diagnostics Outlook - China
90% match

2023-2028 Uterine Sarcoma Therapeutics & Diagnostics Outlook - China

£495.00 28 Sep 2026
2023-2028 Acute Agitation Aggression Treatments Outlook China
90% match

2023-2028 Acute Agitation Aggression Treatments Outlook China

£495.00 28 Sep 2026
2023-2028 Injectable Drug Delivery Devices Outlook China
90% match

2023-2028 Injectable Drug Delivery Devices Outlook China

£495.00 28 Sep 2026
2023-2028 Orphan Diseases Therapeutics CNS China Outlook
89% match

2023-2028 Orphan Diseases Therapeutics CNS China Outlook

£495.00 28 Sep 2026
2023-2028 Orphan Diseases Oncology Therapeutics Outlook China
88% match

2023-2028 Orphan Diseases Oncology Therapeutics Outlook China

£495.00 28 Sep 2026
2023-2028 Nasal Drug Delivery Outlook for China - Market Research
88% match

2023-2028 Nasal Drug Delivery Outlook for China - Market Research

£495.00 28 Sep 2026
2023-2028 Hypercalcemia Treatment Outlook for China
88% match

2023-2028 Hypercalcemia Treatment Outlook for China

£495.00 28 Sep 2026
2023-2028 Compact Advance Radiotherapy Systems Outlook - China
87% match

2023-2028 Compact Advance Radiotherapy Systems Outlook - China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Pet Veterinary Drugs in China
87% match

The 2023-2028 Outlook for Pet Veterinary Drugs in China

£495.00 15 Sep 2026
The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in the United States
87% match

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in the United States
87% match

The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes
87% match

The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes

£490.00 27 Sep 2026
China Contraceptive Implantable Drug Delivery Devices 2023-2028 Outlook
87% match

China Contraceptive Implantable Drug Delivery Devices 2023-2028 Outlook

£495.00 28 Sep 2026
2023-2028 Asthma Spacers Outlook China - Market Analysis
87% match

2023-2028 Asthma Spacers Outlook China - Market Analysis

£495.00 28 Sep 2026
2023-2028 Home Health Care Services Outlook for China
87% match

2023-2028 Home Health Care Services Outlook for China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Orphan Biologic Drugs in India
86% match

The 2023-2028 Outlook for Orphan Biologic Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in the United States
86% match

The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Neurology in the United States
86% match

The 2023-2028 Outlook for Neurology in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in India
86% match

The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in India

£515.00 27 Sep 2026
The 2019-2024 Outlook for Antibody Drugs in China
86% match

The 2019-2024 Outlook for Antibody Drugs in China

£446.25 27 Sep 2026
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States
86% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in India
86% match

The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Pain Management Therapeutics for US Zip Codes
86% match

The 2023-2028 Outlook for Pain Management Therapeutics for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Vasculitis Treatments in India
86% match

The 2023-2028 Outlook for Vasculitis Treatments in India

£515.00 27 Sep 2026